Computed tomography and magnetic resonance imaging of pulmonary hypertension: Pulmonary vessels and right ventricle

Journal of Magnetic Resonance Imaging

Volumn 32, Issue 6, 2010, Pages 1313-1324

  Ley, Sebastian ^a   Grünig, Ekkehard ^b   Kiely, David G ^c   Van Beek, Edwin ^d   Wild, Jim ^e  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

computed tomography; magnetic resonance imaging; pulmonary hypertension

Indexed keywords

ABLAVAR; GADOBUTROL; GADOFOSVESET; GADOLINIUM; UNCLASSIFIED DRUG;

BRONCHIAL ARTERY; CARDIOVASCULAR SYSTEM; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; HEART RIGHT VENTRICLE; LUNG BLOOD VESSEL; LUNG BLOOD VOLUME; LUNG FUNCTION; LUNG PARENCHYMA; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW;

ANGIOGRAPHY; BRONCHI; ELECTROCARDIOGRAPHY; HEART VENTRICLES; HUMANS; HYPERTENSION, PULMONARY; LUNG; MAGNETIC RESONANCE IMAGING; MOTION; PULMONARY ARTERY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78649653344     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22373     Document Type: Review

References (101)

1. Tuder RM, Abman SH, Braun T, et al. Development and pathology of pulmonary hypertension. J Am Coll Cardiol 2009; 54 (1 Suppl): S3-9.
2. Recommendations on the management of pulmonary hypertension in clinical practice. Heart 2001; 86 (Suppl 1): I1-13.
3. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115: 343-349.
4. Boutet K, Montani D, Jais X, et al. Therapeutic advances in pulmonary arterial hypertension. Ther Adv Respir Dis 2008; 2: 249-265.
5. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54 (1 Suppl): S43-54.
6. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009; 119: 2250-2294.
7. Ley S, Kreitner K-F, Fink C, Heussel CP, Borst MM, Kauczor H-U., Assessment of pulmonary hypertension by CT and MR imaging. Eur Radiol 2004; 14: 359-368.
8. Nagendran J, Michelakis E,. MRI: one-stop shop for the comprehensive assessment of pulmonary arterial hypertension? Chest 2007; 132: 2-5.
9. Sallach SM, Peshock RM, Reimold S., Noninvasive cardiac imaging in pulmonary hypertension. Cardiol Rev 2007; 15: 97-101.
10. Resten A, Maitre S, Humbert M, et al. Pulmonary arterial hypertension: thin-section CT predictors of epoprostenol therapy failure. Radiology 2002; 222: 782-788.
11. Devaraj A, Hansell DM., Computed tomography signs of pulmonary hypertension: old and new observations. Clin Radiol 2009; 64: 751-760.
12. Gluecker T, Capasso P, Schnyder P, et al. Clinical and radiologic features of pulmonary edema. Radiographics 1999; 19: 1507-1531; discussion 1532-1533.
13. Resten A, Maitre S, Humbert M, et al. Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease. AJR Am J Roentgenol 2004; 183: 65-70.
14. Markart P, Ghofrani HA, Grimminger F, Gunther A,. [Pulmonary hypertension in COPD and interstitial lung diseases.] Dtsch Med Wochenschr 2009; 134 (Suppl 5): S164-166.
15. Sumikawa H, Johkoh T, Colby TV, et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am J Respir Crit Care Med 2008; 177: 433-439.
16. Heidemann RM, Griswold MA, Kiefer B, et al. Resolution enhancement in lung 1H imaging using parallel imaging methods. Magn Reson Med 2003; 49: 391-394.
17. Arnold JF, Morchel P, Glaser E, Pracht ED, Jakob PM., Lung MRI using an MR-compatible active breathing control (MR-ABC). Magn Reson Med 2007; 58: 1092-1098.
18. Puderbach M, Hintze C, Ley S, Eichinger M, Kauczor HU, Biederer J,. MR imaging of the chest: a practical approach at 1.5T. Eur J Radiol 2007; 64: 345-355.
19. Ley-Zaporozhan J, Ley S, Sommerburg O, Komm N, Muller FM, Schenk JP., Clinical application of MRI in children for the assessment of pulmonary diseases. Rofo 2009; 181: 419-432.
20. Failo R, Wielopolski PA, Tiddens HA, Hop WC, Mucelli RP, Lequin MH., Lung morphology assessment using MRI: a robust ultra-short TR/TE 2D steady state free precession sequence used in cystic fibrosis patients. Magn Reson Med 2009; 61: 299-306.
21. Griswold MA, Jakob PM, Heidemann RM, et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 2002; 47: 1202-1210.
22. Ley-Zaporozhan J, Ley S, Kauczor HU., Proton MRI in COPD. COPD 2007; 4: 55-65.
23. Ley-Zaporozhan J, Ley S, Eberhardt R, Kauczor HU, Heussel CP., Visualization of morphological parenchymal changes in emphysema: comparison of different MRI sequences to 3D-HRCT. Eur J Radiol 2010; 73: 43-49.
24. Biederer J, Both M, Graessner J, et al. Lung morphology: fast MR imaging assessment with a volumetric interpolated breath-hold technique: initial experience with patients. Radiology 2003; 226: 242-249.
25. McLaughlin VV., Primary pulmonary hypertension. Hospital Physician Board Review Manual 2002; 9: 1-11.
26. Yi ES, Kim H, Ahn H, et al. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. Am J Respir Crit Care Med 2000; 162 (4 Pt 1): 1577-1586.
27. Chatterjee K, De Marco T, Alpert JS., Pulmonary hypertension: hemodynamic diagnosis and management. Arch Intern Med 2002; 162: 1925-1933.
28. Perloff JK, Hart EM, Greaves SM, Miner PD, Child JS., Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension. Am J Cardiol 2003; 92: 182-187.
29. Sheehan R, Perloff JK, Fishbein MC, Gjertson D, Aberle DR., Pulmonary neovascularity: a distinctive radiographic finding in Eisenmenger syndrome. Circulation 2005; 112: 2778-2785.
30. Griffin N, Allen D, Wort J, Rubens M, Padley S,. Eisenmenger syndrome and idiopathic pulmonary arterial hypertension: do parenchymal lung changes reflect aetiology? Clin Radiol 2007; 62: 587-595.
31. Stern EJ, Muller NL, Swensen SJ, Hartman TE., CT mosaic pattern of lung attenuation: etiologies and terminology. J Thorac Imaging 1995; 10: 294-297.
32. Castaner E, Gallardo X, Ballesteros E, et al. CT diagnosis of chronic pulmonary thromboembolism. Radiographics 2009; 29: 31-50; discussion 50-33.
33. Schwickert HC, Schweden F, Schild HH, et al. Pulmonary arteries and lung parenchyma in chronic pulmonary embolism: preoperative and postoperative CT findings. Radiology 1994; 191: 351-357.
34. Gorgos A, Remy-Jardin M, Duhamel A, et al. Evaluation of peripheral pulmonary arteries at 80 kV and at 140 kV: dual-energy computed tomography assessment in 51 patients. J Comput Assist Tomogr 2009; 33: 981-986.
35. Fink C, Puderbach M, Bock M, et al. Regional lung perfusion: assessment with partially parallel three-dimensional MR imaging. Radiology 2004; 231: 175-184.
36. Ohno Y, Murase K, Higashino T, et al. Assessment of bolus injection protocol with appropriate concentration for quantitative assessment of pulmonary perfusion by dynamic contrast-enhanced MR imaging. J Magn Reson Imaging 2007; 25: 55-65.
37. Ley S, Fink C, Zaporozhan J, et al. Value of high spatial and high temporal resolution magnetic resonance angiography for differentiation between idiopathic and thromboembolic pulmonary hypertension: initial results. Eur Radiol 2005; 15: 2256-2263.
38. Ohno Y, Hatabu H, Murase K, et al. Primary pulmonary hypertension: 3D dynamic perfusion MRI for quantitative analysis of regional pulmonary perfusion. AJR Am J Roentgenol 2007; 188: 48-56.
39. Ley S, Mereles D, Risse F, et al. Quantitative 3D pulmonary MR-perfusion in patients with pulmonary arterial hypertension: correlation with invasive pressure measurements. Eur J Radiol 2007; 61: 251-255.
40. Ley S, Gruenig E, Risse F, Ehlken N, Mereles D, Kauczor H-U., Treatment monitoring in patients with pulmonary arterial hypertension (PAH) using quantitative 3D MR pulmonary perfusion. Abstract presented at: The European Congress of Radiology (ECR); March, 2008; Vienna, Austria.
41. Wild JM, Fichele S, Woodhouse N, Paley MN, Kasuboski L, van Beek EJ., 3D volume-localized pO2 measurement in the human lung with 3He MRI. Magn Reson Med 2005; 53: 1055-1064.
42. Patz S, Muradian I, Hrovat MI, et al. Human pulmonary imaging and spectroscopy with hyperpolarized 129Xe at 0.2T. Acad Radiol 2008; 15: 713-727.
43. Rizi RR, Baumgardner JE, Ishii M, et al. Determination of regional VA/Q by hyperpolarized 3He MRI. Magn Reson Med 2004; 52: 65-72.
44. Deveraj A, Wells AU, Meister M,. The reliability of CT signs in mild and severe pulmonary hypertension. Eur Radiol Suppl 2008; 18: 329.
45. Bugnone AN, Viamonte M Jr, Garcia H,. Imaging findings in human immunodeficiency virus-related pulmonary hypertension: report of five cases and review of the literature. Radiology 2002; 223: 820-827.
46. Ng CS, Wells AU, Padley SP., A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 1999; 14: 270-278.
47. Lawler LP, Corl FM, Fishman EK., Multi-detector row and volume-rendered CT of the normal and accessory flow pathways of the thoracic systemic and pulmonary veins. Radiographics 2002; 22 (Spec No): S45-60.
48. Hoey ET, Gopalan D, Agrawal SK, Screaton NJ., Cardiac causes of pulmonary arterial hypertension: assessment with multidetector CT. Eur Radiol 2009; 19: 2557-2568.
49. Remy-Jardin M, Pistolesi M, Goodman LR, et al. Management of suspected acute pulmonary embolism in the era of CT angiography: a statement from the Fleischner Society. Radiology 2007; 245: 315-329.
50. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29: 2276-2315.
51. McGoon MD., The assessment of pulmonary hypertension. Clin Chest Med 2001; 22: 493-508.
52. Williamson TL, Kim NH, Rubin LJ., Chronic thromboembolic pulmonary hypertension. Prog Cardiovasc Dis 2002; 45: 203-212.
53. Hagl C, Khaladj N, Peters T, et al. Technical advances of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Eur J Cardiothorac Surg 2003; 23: 776-781.
54. Paul JF, Khallil A, Sigal-Cinqualbre A, et al. Findings on submillimeter MDCT are predictive of operability in chronic thromboembolic pulmonary hypertension. AJR Am J Roentgenol 2007; 188: 1059-1062.
55. Ley S, Kauczor HU., MR imaging/magnetic resonance angiography of the pulmonary arteries and pulmonary thromboembolic disease. Magn Reson Imaging Clin N Am 2008; 16: 263-273.
56. Oberholzer K, Romaneehsen B, Kunz P, Kramm T, Thelen M, Kreitner KF,. [Contrast-enhanced 3D MR angiography of the pulmonary arteries with integrated parallel acquisition technique (iPAT) in patients with chronic-thromboembolic pulmonary hypertension CTEPH - sagittal or coronal acquisition?] Fortschr Röntgenstr Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2004; 176: 605-609.
57. Kreitner KF, Kunz RP, Ley S, et al. Chronic thromboembolic pulmonary hypertension - assessment by magnetic resonance imaging. Eur Radiol 2007; 17: 11-21.
58. Fink C, Bock M, Kiessling F, et al. Time-resolved contrast-enhanced three-dimensional pulmonary MR-angiography: 1.0 M gadobutrol vs. 0.5 M gadopentetate dimeglumine. J Magn Reson Imaging 2005; 19: 202-208.
59. Oudkerk M, van Beek EJ, Wielopolski P, et al. Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study. Lancet 2002; 359: 1643-1647.
60. van Beek EJ, Wild JM, Fink C, Moody AR, Kauczor HU, Oudkerk M., MRI for the diagnosis of pulmonary embolism. J Magn Reson Imaging 2003; 18: 627-640.
61. Krishnam MS, Tomasian A, Deshpande V, et al. Non-contrast 3D SSFP MR angiography of the whole chest using non-selective RF excitation over a large field of view: comparison with single-phase 3D contrast-enhanced MRA. Invest Radiol 2008; 43: 411-420.
62. Kreitner KF, Ley S, Kauczor HU, et al. Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques. Radiology 2004; 232: 535-543.
63. Nikolaou K, Schoenberg SO, Attenberger U, et al. Pulmonary arterial hypertension: diagnosis with fast perfusion MR imaging and high-spatial- resolution MR angiography-preliminary experience. Radiology 2005; 236: 694-703.
64. Virchow RL., Gesammelte Werke. In:, Meidinger, ed. Gesammelte Abhandlungen zur wissenschaftlichen Medicin. Frankfurt a.M.: Meidinger Sohn & Co; 1856; 219-732.
65. Baile EM, Ling H, Heyworth JR, Hogg JC, Pare PD., Bronchopulmonary anastomotic and noncoronary collateral blood flow in humans during cardiopulmonary bypass. Chest 1985; 87: 749-754.
66. Robertson HT, Jindal SK, Lakshminarayan S, et al. Gas exchange properties of the bronchial circulation in a dog lobe maintained in zone 1 conditions. Am Rev Respir Dis 1984; 129: A229.
67. Kauczor H-U, Schwickert HC, Mayer E, Schweden F, Schild HH, Thelen M., Spiral CT of bronchial arteries in chronic thromboembolism. J Comput Assist Tomogr 1994; 18: 855-861.
68. Heinrich M, Uder M, Tscholl D, Grgic A, Kramann B, Schafers HJ., CT scan findings in chronic thromboembolic pulmonary hypertension: predictors of hemodynamic improvement after pulmonary thromboendarterectomy. Chest 2005; 127: 1606-1613.
69. Shimizu H, Tanabe N, Terada J, et al. Dilatation of bronchial arteries correlates with extent of central disease in patients with chronic thromboembolic pulmonary hypertension. Circ J 2008; 72: 1136-1141.
70. Caso P, Galderisi M, Cicala S, et al. Association between myocardial right ventricular relaxation time and pulmonary arterial pressure in chronic obstructive lung disease: analysis by pulsed Doppler tissue imaging. J Am Soc Echocardiogr 2001; 14: 970-977.
71. Nakamura K, Miyahara Y, Ikeda S, Naito T., Assessment of right ventricular diastolic function by pulsed Doppler echocardiography in chronic pulmonary disease and pulmonary thromboembolism. Respiration 1995; 62: 237-243.
72. Carrascosa PM, Capunay CM, Parodi JC, et al. General utilities of multislice tomography in the cardiac field. Herz 2003; 28: 44-51.
73. Wintersperger BJ, Stäbler A, Seemann M, et al. [Evaluation of right ventricular performance in patients with acute pulmonary embolism by helical CT.] Fortschr Röntgenstr 1999; 170: 542-549.
74. Halliburton SS, Petersilka M, Schvartzman PR, Obuchowski N, White RD., Evaluation of left ventricular dysfunction using multiphasic reconstructions of coronary multi-slice computed tomography data in patients with chronic ischemic heart disease: validation against cine magnetic resonance imaging. Int J Cardiovasc Imaging 2003; 19: 73-83.
75. Contractor S, Maldjian PD, Sharma VK, Gor DM., Role of helical CT in detecting right ventricular dysfunction secondary to acute pulmonary embolism. J Comput Assist Tomogr 2002; 26: 587-591.
76. Nicol ED, Kafka H, Stirrup J, et al. A single, comprehensive non-invasive cardiovascular assessment in pulmonary arterial hypertension: combined computed tomography pulmonary and coronary angiography. Int J Cardiol 2009; 136: 278-288.
77. Bruzzi JF, Remy-Jardin M, Delhaye D, Teisseire A, Khalil C, Remy J,. When, why, and how to examine the heart during thoracic CT. Part 1. Basic principles. AJR Am J Roentgenol 2006; 186: 324-332.
78. Jakobs TF, Becker CR, Ohnesorge B, et al. Multislice helical CT of the heart with retrospective ECG gating: reduction of radiation exposure by ECG-controlled tube current modulation. Eur Radiol 2002; 12: 1081-1086.
79. Hein PA, Romano VC, Lembcke A, May J, Rogalla P., Initial experience with a chest pain protocol using 320-slice volume MDCT. Eur Radiol 2009; 19: 1148-1155.
80. Revel MP, Faivre JB, Remy-Jardin M, Delannoy-Deken V, Duhamel A, Remy J., Pulmonary hypertension: ECG-gated 64-section CT angiographic evaluation of new functional parameters as diagnostic criteria. Radiology 2009; 250: 558-566.
81. Kovacs G, Reiter G, Reiter U, Rienmuller R, Peacock A, Olschewski H., The emerging role of magnetic resonance imaging in the diagnosis and management of pulmonary hypertension. Respiration 2008; 76: 458-470.
82. McLure LE, Peacock AJ., Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension. Eur Respir J 2009; 33: 1454-1466.
83. Pattynama PMT, Lamb HJ, van der Velde EA, van der Geest RJ, van der Wall EE, de Roos A., Reproducibilty of MRI-derived measurements of right ventricular volumes and myocardial mass. J Magn Reson Imaging 1995; 13: 53-63.
84. Chatzimavroudis GP, Oshinski JN, Franch RH, Walker PG, Yoganathan AP, Pettigrew RI., Evaluation of the precision of magnetic resonance phase velocity mapping for blood flow measurements. J Cardiovasc Magn Reson 2001; 3: 11-19.
85. Rominger MB, Bachmann GF, Pabst W, Rau WS., Right ventricular volumes and ejection fraction with fast cine MR imaging in breath-hold technique: applicability, normal values from 52 volunteers, and evaluation of 325 adult cardiac patients. J Magn Reson Imaging 1999; 10: 908-918.
86. Finn JP, Nael K, Deshpande V, Ratib O, Laub G., Cardiac MR imaging: state of the technology. Radiology 2006; 241: 338-354.
87. Hagger D, Condliffe R, Woodhouse N, et al. Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension. Rheumatology (Oxford) 2009; 48: 1137-1142.
88. Dellegrottaglie S, Sanz J, Poon M, et al. Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. Radiology 2007; 243: 63-69.
89. Roeleveld RJ, Marcus JT, Faes TJ, et al. Interventricular septal configuration at mr imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology 2005; 234: 710-717.
90. Lotz J, Meier C, Leppert A, Galanski M., Cardiovascular flow measurement with phase-contrast MR imaging: basic facts and implementation. Radiographics 2002; 22: 651-671.
91. Ley S, Unterhinninghofen R, Ley-Zaporozhan J, Schenk JP, Kauczor HU, Szabo G., Validation of MR phase-contrast flow measurements in the main pulmonary artery and aorta using perivascular ultrasound in a large animal model. Invest Radiol 2008; 43: 421-426.
92. Ley S, Mereles D, Puderbach M, et al. Value of MR phase-contrast flow measurements for functional assessment of pulmonary arterial hypertension. Eur Radiol 2007; 17: 1892-1897.
93. Sanz J, Kariisa M, Dellegrottaglie S, et al. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging 2009; 2: 286-295.
94. Ley S, Puderbach M, Fink C, et al. Assessment of hemodynamic changes in the systemic and pulmonary arterial circulation in patients with cystic fibrosis using phase-contrast MRI. Eur Radiol 2005; 15: 1575-1580.
95. Roeleveld RJ, Marcus JT, Boonstra A, et al. A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension. J Magn Reson Imaging 2005; 22: 67-72.
96. Sanz J, Kuschnir P, Rius T, et al. Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. Radiology 2007; 243: 70-79.
97. Laffon E, Laurent F, Bernard V, De Boucaud L, Ducassou D, Marthan R., Noninvasive assessment of pulmonary arterial hypertension by MR phase-mapping method. J Appl Physiol 2001; 90: 2197-2202.
98. Abolmaali N, Seitz U, Esmaeili A, et al. Evaluation of a resistance-based model for the quantification of pulmonary arterial hypertension using MR flow measurements. J Magn Reson Imaging 2007; 26: 646-653.
99. Nogami M, Ohno Y, Koyama H, et al. Utility of phase contrast MR imaging for assessment of pulmonary flow and pressure estimation in patients with pulmonary hypertension: comparison with right heart catheterization and echocardiography. J Magn Reson Imaging 2009; 30: 973-980.
100. Unterhinninghofen R, Ley S, Ley-Zaporozhan J, et al. Concepts for visualization of multidirectional phase-contrast MRI of the heart and large thoracic vessels. Acad Radiol 2008; 15: 361-369.
101. Reiter G, Reiter U, Kovacs G, et al. Magnetic resonance-derived 3-dimensional blood flow patterns in the main pulmonary artery as a marker of pulmonary hypertension and a measure of elevated mean pulmonary arterial pressure. Circ Cardiovasc Imaging 2008; 1: 23-30.